4//SEC Filing
Rowland Thomas Andrew 4
Accession 0001507496-25-000004
CIK 0001023024other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:15 PM ET
Size
5.0 KB
Accession
0001507496-25-000004
Insider Transaction Report
Form 4
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
Transactions
- Tax Payment
Common Stock
2025-02-28$61.89/sh−627$38,805→ 45,465 total
Footnotes (1)
- [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,171 shares of restricted stock, the grant of which was previously reported.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001507496
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:15 PM ET
- Size
- 5.0 KB